FULPHILA

Approval Id: de5800722d572d6b
Drug Approval Canada Name: FULPHILA
Product Name: FULPHILA
Status: Marketed
Status Date: 2024-04-04
Original Market Date: 2020-02-07
Din: 02484153
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 20:16.00
Atc Original: L03AA13 PEGFILGRASTIM
Atc Name: l 03 aa 13
Aig Number: 0149962001
Company Name: Biosimilar Collaborations Ireland Ltd.
Company Address: UNIT 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Dublin, --, Ireland, D13R20R
Company Detail Path: /organization/biosimilar-collaborations-ireland-ltd

PEGFILGRASTIM

10 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

de5800722d572d6b

Type

Standard